Liver Disease News and Research

RSS
Risk prediction model can help target hepatitis C treatment to patients with most urgent need

Risk prediction model can help target hepatitis C treatment to patients with most urgent need

CLDF collaborates with Walgreens to offer free rapid HCV testing

CLDF collaborates with Walgreens to offer free rapid HCV testing

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Monash University-led researchers call for HCV patients to gain improved access to effective drugs

Monash University-led researchers call for HCV patients to gain improved access to effective drugs

MD Anderson researchers find significant clinical variations among liver cancer patients

MD Anderson researchers find significant clinical variations among liver cancer patients

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Brain protein plays key role in controlling binge drinking

Brain protein plays key role in controlling binge drinking

Misperceptions about miscarriage are widespread, survey finds

Misperceptions about miscarriage are widespread, survey finds

New data driven approach to healthcare

New data driven approach to healthcare

SLU professor reveals why women have higher rates of strokes than men, suggests steps to reduce risk

SLU professor reveals why women have higher rates of strokes than men, suggests steps to reduce risk

Hepatitis C common among HIV-positive patients in sub-Saharan Africa

Hepatitis C common among HIV-positive patients in sub-Saharan Africa

Investigational three-drug combination clears hepatitis C in 93% of patients with liver cirrhosis

Investigational three-drug combination clears hepatitis C in 93% of patients with liver cirrhosis

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

New study finds high levels of HCV infection among HIV-infected people across Africa

New study finds high levels of HCV infection among HIV-infected people across Africa

Montefiore and Einstein researchers to present data on obesity, asthma and autism at PAS 2015

Montefiore and Einstein researchers to present data on obesity, asthma and autism at PAS 2015

SLU selected to work on universal flu vaccine project

SLU selected to work on universal flu vaccine project

New study finds that sexual function in adult living donors lower at three months after transplant

New study finds that sexual function in adult living donors lower at three months after transplant

Preventive intervention improves knowledge, attitudes about sexual risk among adolescent boys than girls

Preventive intervention improves knowledge, attitudes about sexual risk among adolescent boys than girls

Will new hepatitis C treatments strain payers’ budgets? An interview with Dr Chhatwal

Will new hepatitis C treatments strain payers’ budgets? An interview with Dr Chhatwal

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.